No definition available.
Other bacterial agents as the cause of diseases classified to other chapters
AB1_OTHER_BACT_INOTHER
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
354 |
4. Check minimum number of eventsNone |
354 |
5. Include endpointsNone |
354 |
6. Filter based on genotype QC (FinnGen only) |
354 |
Control definitions (FinnGen only)
- Control exclude
- AB1_BACT_BIR_OTHER_INF_AGENTS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other bacterial agents as the cause of diseases classified to other chapters
based on the number of shared cases.
Similar with more cases:
- Bacterial, viral and other infectious agents
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3169 | 1962 | 1175 |
| Only index persons | 2334 | 1415 | 919 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.03 |
| Only index persons | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 62.07 | 63.04 | 60.18 |
| Only index persons | 53.67 | 53.02 | 54.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 354 | 217 | 137 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.06 |
| Median age at first event (years) | 57.16 | 53.73 | 62.59 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 319
- Matched controls
- 3189
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B96.2
ICD-10 Finland
Escherichia coli [E. coli] as the cause of diseases classified to other chapters
+∞
140.2
124
*
B96.5
ICD-10 Finland
Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters
+∞
78.4
72
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
10.3
64.3
148
247
B96.1
ICD-10 Finland
Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters
+∞
43.8
41
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
20.4
41.5
63
38
J01MA02
ATC
ciprofloxacin; systemic
4.2
31.9
191
839
A41.8
ICD-10 Finland
Other specified sepsis
27.9
25.9
35
14
B96.88
ICD-10 Finland
Other specified bacterial agents as the cause of diseases classified to other chapters
+∞
23.2
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
23.2
77
179
A41.9
ICD-10 Finland
Sepsis, unspecified
11.2
22.9
44
45
J01MA12
ATC
levofloxacin; systemic
3.9
21.6
104
348
R50.9
ICD-10 Finland
Fever, unspecified
4.3
21.0
89
265
B96.80
ICD-10 Finland
Campylo bacterial infection causing disease classified in other paragraph
+∞
18.9
18
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.8
18.4
90
300
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
16.3
44
78
J01EA01
ATC
trimethoprim; systemic
2.8
15.5
127
601
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
14.7
14
*
B96.0
ICD-10 Finland
Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters
+∞
14.7
14
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
14.5
13.9
23
17
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
13.5
109
503
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
10.7
13.2
25
25
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
13.1
95
410
C03CA01
ATC
furosemide; systemic
2.5
12.9
131
686
127
Kela drug reimbursment
Transplant complication
12.3
12.5
22
19
J01FF01
ATC
clindamycin; systemic
2.7
12.5
108
516
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
10.3
12.5
24
25
A11CC03
ATC
alfacalcidol; systemic
9.3
12.3
25
29
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.9
12.0
81
333
J47
ICD-10 Finland
Bronchiectasis
13.2
11.8
20
16
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.4
11.5
23
26
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
11.4
38
87
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.3
11.4
30
52
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.9
11.3
37
83
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
11.1
65
241
ZX120
NOMESCO Finland
Intravenous
3.9
11.1
47
136
TK800
NOMESCO Finland
Hemodialysis
10.1
10.9
21
22
J01MA06
ATC
norfloxacin; oral
3.0
10.8
67
256
UKC02
NOMESCO Finland
Cystoscopy
2.9
10.6
71
289
J01MA14
ATC
moxifloxacin; systemic
3.8
10.2
43
124
TQW11
NOMESCO Finland
Vacuum treatment of wound
10.5
9.6
18
18
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.6
9.6
33
78
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
9.6
65
264
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
9.5
35
89
B96.7
ICD-10 Finland
Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters
+∞
9.4
9
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.8
9.3
40
117
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
9.3
123
708
B03XA02
ATC
darbepoetin alfa; parenteral
9.5
9.2
18
20
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.9
9.0
37
104
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
9.0
47
161
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
8.8
152
976
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.7
8.6
21
33
L04AD01
ATC
ciclosporin; systemic
8.2
8.5
18
23
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.1
8.5
26
55
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
8.4
72
333
L04AA06
ATC
mycophenolic acid; systemic
8.9
8.4
17
20
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
8.4
69
312
J01XE01
ATC
nitrofurantoin; oral
7.4
8.4
19
27
N18.8
ICD-10 Finland
Other chronic renal failure
6.6
8.2
20
32
Z94.0
ICD-10 Finland
Kidney transplant status
12.1
8.1
14
12
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.0
8.1
32
87
L04AA01
ATC
[U] ciclosporin; systemic
9.3
8.1
16
18
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
10.4
8.1
15
15
J01MA01
ATC
ofloxacin; systemic
3.2
8.0
44
153
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.2
7.8
23
47
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
46.1
7.7
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.4
7.5
35
110
J01CA08
ATC
pivmecillinam; oral
2.0
7.5
138
893
H02AB06
ATC
prednisolone; systemic
1.9
7.5
158
1073
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
7.4
103
595
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.1
7.4
41
144
A12AA04
ATC
calcium carbonate; oral
9.7
7.4
14
15
J01XB01
ATC
colistin; inhalant, parenteral
+∞
7.3
7
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
16.2
7.3
11
7
R03AK11
ATC
formoterol and fluticasone; inhalant
8.2
7.2
15
19
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.3
7.2
18
30
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.4
7.1
34
109
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.1
98
563
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
7.1
62
289
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.4
7.1
13
13
J01DA01
ATC
[U] cefalexin; systemic
1.9
6.8
201
1517
N30.9
ICD-10 Finland
Cystitis, unspecified
3.3
6.8
33
108
J02AC01
ATC
fluconazole; systemic
1.9
6.7
122
776
H02AB07
ATC
prednisone; oral
2.5
6.7
55
249
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
6.7
33
109
N06AX21
ATC
duloxetine; oral
2.9
6.7
40
151
N03AX16
ATC
pregabalin; oral
2.1
6.7
85
472
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
6.6
42
163
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
6.5
163
1155
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
6.5
66
329
WW500
NOMESCO Finland
Blood transfusion
4.5
6.4
21
49
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
6.3
69
355
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
18.5
6.3
9
5
U88
ICD-10 Finland
Agent resistant to multiple antibiotics
+∞
6.3
6
*
G04AC01
ATC
NA
4.4
6.2
21
50
L04AX01
ATC
azathioprine; systemic
4.0
6.2
23
60
J01XX05
ATC
methenamine; oral
7.9
6.2
13
17
M04AA01
ATC
allopurinol; systemic
2.4
6.2
53
243
A10AA02
ATC
NA
5.1
6.1
18
37
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.3
6.1
21
51
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
12.8
6.1
10
8
H02AB04
ATC
methylprednisolone; systemic
2.3
6.1
56
268
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.9
6.1
14
21
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
6.1
64
325
N02AX02
ATC
tramadol; systemic, rectal
1.8
6.0
130
873
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
171
755
3.45
28.89
10.8
4.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
32
34
10.25
27.48
9.1
2.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
40
78
5.65
20.08
3.6
8.7
u/ml
0.4
0.4
0.02
21
44
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
52
6.67
19.27
1.9
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
52
6.67
19.27
1.9
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
65
211
3.55
16.95
2.1
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
100
436
2.80
15.67
7.6
4.3
mmol/l
0.8
0.8
0.15
91
410
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
51
5.88
15.02
12.1
7.8
iu/ml
172.0
611.2
—
7
9
(3005719) IgG [Mass/volume] in Serum or Plasma
63
216
3.33
15.00
3.7
2.9
g/l
9.5
10.1
0.54
57
199
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
466
2.71
14.95
3.3
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
160
904
2.40
14.39
13.4
6.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
196
1233
2.32
13.48
13.8
6.3
%
0.6
0.6
0.37
186
1154
(3028026) IgM [Mass/volume] in Serum or Plasma
53
180
3.29
12.74
2.9
1.7
g/l
1.5
1.8
0.19
46
164
(3019069) Monocytes/100 leukocytes in Blood
199
1280
2.27
12.72
14.1
6.5
%
8.5
8.5
0.07
189
1210
(3006504) Eosinophils/100 leukocytes in Blood
198
1273
2.26
12.65
13.7
6.2
%
2.5
2.8
1.52
187
1192
(3007853) Bacteria identified in Skin by Aerobe culture
76
319
2.76
12.57
3.3
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
35
6.32
12.27
6.1
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
86
391
2.58
12.11
4.7
2.3
g/l
2.1
2.3
4.00
79
355
(3002030) Lymphocytes/100 leukocytes in Blood
201
1316
2.22
12.08
14.1
6.3
%
25.5
27.9
2.07
190
1238
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
84
4.23
12.03
5.4
3.3
—
—
—
0
0
(3026782) Osmolality of Urine
114
598
2.34
11.70
5.9
2.7
mosm/kgh2o
494.7
558.1
2.76
97
506
(3018010) Neutrophils/100 leukocytes in Blood
198
1304
2.18
11.53
13.2
6.1
%
60.7
57.1
3.57
185
1233
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
373
2.56
11.48
5.1
2.4
%
16.5
22.4
5.48
75
327
(3027945) Reticulocytes/100 erythrocytes in Blood
73
322
2.60
10.85
4.3
3.2
%
1.9
1.8
0.18
62
297
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
5
29.05
10.80
2.6
3.2
mg/l
0.9
1.1
—
9
5
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
56
219
2.85
10.49
8.8
3.6
ng/l
131.6
75.5
3.03
47
200
(36304419) Bacteria [Presence] in Urine
135
789
2.15
10.44
6.3
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
215
1497
2.11
10.42
11.0
6.4
umol/l
10.1
11.3
1.27
200
1407
(3024561) Albumin [Mass/volume] in Serum or Plasma
180
1177
2.08
10.29
8.9
4.8
g/l
32.7
35.5
6.30
161
1106
(3002032) Base excess in Venous blood by calculation
64
272
2.65
10.22
9.0
4.3
mmol/l
1.4
1.8
0.36
57
210
(3042936) Bacteria identified in Isolate by Culture
86
421
2.38
10.18
3.8
1.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
50
4.85
10.15
6.7
3.3
%
51.8
60.0
2.21
23
50
(3030467) Casts [#/volume] in Urine by Automated count
137
814
2.11
10.08
6.4
3.1
e6/l
0.6
0.5
0.05
114
610
(3000991) Gas panel - Venous blood
58
237
2.73
9.99
17.2
9.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
200
1375
2.04
9.80
13.0
6.0
e9/l
0.0
0.0
0.09
181
1191
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
36
5.52
9.74
1.5
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
70
318
2.50
9.72
3.0
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
225
1620
2.07
9.63
16.4
9.4
e9/l
4.5
4.1
1.63
201
1418
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
89
3.72
9.58
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
203
1411
2.03
9.56
13.7
6.3
e9/l
0.2
0.2
0.23
184
1241
(3000850) Epithelial cells [#/volume] in Urine
112
628
2.15
9.48
5.2
2.5
e6/l
5.5
6.6
0.29
98
555
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
37
5.37
9.47
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
37
5.37
9.47
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
37
5.37
9.47
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
37
5.37
9.47
1.5
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
198
1369
2.01
9.41
13.1
6.0
e9/l
0.6
0.6
1.68
179
1184
(3002582) Erythrocytes [#/volume] in Urine
145
898
2.04
9.40
6.6
3.2
e6/l
27.3
133.8
0.85
120
695
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
46
173
2.91
9.23
3.0
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
38
5.23
9.20
1.5
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
174
1162
1.98
9.00
3.6
2.3
nmol/l
80.2
77.3
0.61
156
1032
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
39
5.09
8.94
2.2
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
60
4.22
8.94
2.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
201
1413
1.98
8.93
13.5
6.0
e9/l
1.7
1.8
1.57
184
1244
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
15
8.25
8.91
1.4
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
28
5.94
8.88
8.5
4.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
233
2.61
8.79
5.0
3.0
e9/l
76.2
73.0
0.11
38
177
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
25
6.22
8.72
1.2
1.2
g/l
0.4
0.4
—
10
20
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
25
6.22
8.72
1.2
1.2
g/l
2.4
2.6
—
10
20
(3021440) Promyelocytes/100 leukocytes in Blood
51
209
2.68
8.70
5.7
4.9
%
0.3
0.1
0.33
26
65
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
159
1040
1.96
8.64
6.4
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
68
323
2.37
8.51
3.1
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
49
200
2.68
8.42
5.7
4.6
%
0.8
0.4
0.87
22
49
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
197
1395
1.93
8.36
16.7
6.8
mmol/l
1.2
1.2
0.37
162
1171
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
46
4.55
8.26
2.4
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
196
2.68
8.24
9.2
5.5
mmol/l
1.6
1.6
0.00
40
147
(3000494) Fungus identified in Specimen by Culture
68
328
2.33
8.20
2.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
47
4.45
8.04
2.3
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
180
2.72
8.04
2.0
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
31
5.36
8.00
2.4
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
119
3.05
7.72
2.2
2.2
g/l
1.7
1.5
0.33
28
102
(3004588) Protein electrophoresis panel - Serum or Plasma
44
179
2.67
7.60
3.6
2.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
15
7.54
7.59
1.5
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
83
3.44
7.55
2.6
4.4
mg/l
251.4
30.1
0.48
20
65
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
54
4.07
7.54
2.4
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
51
224
2.49
7.54
3.6
3.1
g/l
64.5
66.2
0.84
45
204
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
334
2.24
7.45
5.2
3.1
umol/l
7.9
8.6
0.12
53
291
(3007164) IgA [Mass/volume] in Serum or Plasma
107
637
1.97
7.45
1.7
1.4
g/l
2.3
2.4
0.17
72
378
(3037756) Immunofixation for Serum or Plasma
23
64
3.77
7.43
2.2
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
144
947
1.88
7.42
4.7
3.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
79
3.47
7.40
3.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
227
2.46
7.33
5.8
4.7
%
0.9
0.9
0.04
26
74
(4062490)
14
26
5.57
7.31
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
48
208
2.51
7.30
9.4
5.4
ph
7.4
7.4
0.16
11
24
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
470
2.06
7.25
5.0
3.0
e6/l
2.1
2.6
0.45
59
262
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
48
209
2.50
7.22
9.4
5.3
kpa
5.1
5.1
0.01
48
197
(3018095) Leukocytes [#/volume] in Urine
154
1042
1.85
7.20
7.7
3.8
e6/l
50.9
91.5
1.22
125
744
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
13
7.89
7.15
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
13
7.89
7.15
1.5
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
26
81
3.39
7.12
2.6
4.4
—
4.0
—
0
6
(3034860) Kappa light chains.free [Mass/volume] in Serum
26
83
3.30
6.86
2.7
4.4
mg/l
51.7
61.4
0.19
20
65
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
56
269
2.29
6.77
3.6
2.2
g/l
0.2
0.2
0.22
51
252
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
54
3.87
6.73
2.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
14
7.32
6.73
3.0
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
45
198
2.46
6.62
6.2
5.0
%
0.0
0.2
0.35
22
55
(3001122) Ferritin [Mass/volume] in Serum or Plasma
173
1239
1.78
6.51
4.8
2.7
ug/l
198.1
109.3
1.67
151
1138
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
18
6.28
6.47
2.8
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
161
1135
1.77
6.35
16.2
9.1
inr
1.3
1.2
0.88
55
344
(1616796) Gas panel - Central venous blood
20
57
3.66
6.25
8.3
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
85
494
1.95
6.22
4.6
2.7
e6/l
0.7
0.8
0.10
58
282
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
73
3.30
6.13
1.5
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
106
2.89
6.12
3.0
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
217
1677
1.76
6.11
9.1
4.9
mmol/l
6.9
6.7
0.63
206
1542
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
58
3.59
6.10
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
69
3.33
5.98
1.4
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
54
3.66
5.97
2.6
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
30
114
2.78
5.90
3.3
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
157
2.52
5.87
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
155
1105
1.72
5.71
2.2
2.0
pmol/l
88.5
95.8
1.25
80
549
(40760888) Immunoglobulin light chains.free panel - Serum
20
61
3.42
5.67
2.5
5.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
56
3.53
5.67
5.3
3.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
7
13.15
5.61
1.9
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
130
896
1.71
5.34
4.5
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
8
11.50
5.32
2.0
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
64
3.25
5.27
6.3
2.3
%
15.5
15.6
0.05
15
30
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
258
2138
1.76
5.26
16.3
7.5
u/l
92.1
79.6
2.09
242
1990
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
5
0
+∞
5.22
10.4
0.0
ug/min
24.8
—
—
5
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
35
4.12
5.22
2.9
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
26
98
2.78
5.20
7.3
6.9
kpa
8.2
8.5
0.45
26
89
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
129
893
1.70
5.19
4.2
3.2
u/l
30.8
32.4
0.27
122
854
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
31
4.32
5.13
1.5
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
45
3.68
5.10
2.8
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
85
525
1.81
5.08
1.9
1.7
nmol/l
952.8
1236.4
2.57
55
395
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
36
4.01
5.03
1.4
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
170
1273
1.65
5.01
15.9
6.3
mmol/l
1.2
1.2
1.26
155
1153
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
72
3.04
4.96
2.8
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
46
3.60
4.95
1.3
1.9
g/l
0.5
0.9
0.89
11
41
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
126
881
1.67
4.81
4.5
2.5
u/l
51.6
55.3
0.50
118
813
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
10
9.20
4.81
7.9
8.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
63
360
1.91
4.78
25.5
21.3
inr
1.4
1.3
0.17
11
52
(3018418) pH of Serum or Plasma
123
857
1.67
4.75
11.3
3.8
ph
7.4
7.4
0.17
34
172
(3013512) EKG study
117
807
1.67
4.69
4.7
4.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
29
4.25
4.66
1.2
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
75
2.91
4.64
2.7
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
8
10.20
4.54
1.4
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
232
1904
1.63
4.54
8.3
4.8
e6/l
8404.8
1957.4
—
5
34
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
50
3.30
4.39
9.3
2.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
246
2057
1.64
4.38
7.0
4.1
mm/h
20.5
11.7
6.35
223
1882
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
107
734
1.66
4.33
3.4
2.0
mg/l
3.5
3.1
0.66
93
629
(3045142) Bone marrow Pathology biopsy report
13
36
3.71
4.24
2.1
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
98
661
1.67
4.22
4.4
2.7
umol/l
362.2
5882.3
2.63
83
568
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
670
1.66
4.20
3.5
2.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
13
7.07
4.18
3.7
2.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
176
2.16
4.17
4.4
2.1
e9/l
3.9
4.2
0.26
22
137
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
63
2.96
4.12
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
32
3.85
4.12
1.5
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
32
3.85
4.12
2.3
2.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
23
4.45
4.11
1.4
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
281
1.91
3.98
4.8
2.3
u/l
52.3
32.3
0.36
42
234
(3052851) Hemolysis interference index of Serum or Plasma
21
82
2.66
3.96
8.2
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
11
7.41
3.88
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
640
1.64
3.87
4.7
2.0
mg/l
1.3
1.3
0.06
75
495
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
15
6.12
3.84
3.1
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
29
3.88
3.83
2.2
2.1
pg
31.9
32.8
0.31
11
29
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
29
3.88
3.83
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
8
8.90
3.79
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
56
332
1.82
3.78
2.2
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
233
1960
1.55
3.71
8.3
4.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
40
3.34
3.66
2.8
1.7
%
88.4
90.5
0.34
13
40
(40758558) Short blood count panel - Blood
100
701
1.59
3.63
11.9
7.4
—
—
—
0
0
(4035726)
44
245
1.91
3.60
2.0
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
9
7.91
3.57
1.6
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
69
2.69
3.53
2.1
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
79
527
1.64
3.50
2.3
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
117
858
1.54
3.47
4.9
3.4
ng/l
2316.2
1354.9
1.06
102
722
(3024928) Oxygen saturation in Venous blood
16
58
2.84
3.47
6.8
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
155
2.10
3.42
10.5
6.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
53
2.91
3.40
2.5
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
62
391
1.71
3.39
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
27
3.78
3.37
1.9
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
37
3.32
3.37
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
32
3.52
3.36
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
299
1.78
3.28
5.4
3.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
33
3.41
3.22
7.5
2.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
1317
1.47
3.20
6.2
4.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
159
1260
1.48
3.20
22.1
10.2
e9/l
0.0
0.0
0.61
136
1031
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
204
1.91
3.13
1.9
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
42
242
1.83
3.11
2.3
2.4
ug/l
20.1
7.6
0.60
31
211
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
949
1.49
3.09
4.0
3.3
mmol/l
2.3
2.4
1.21
103
828
(3018677) aPTT in Platelet poor plasma by Coagulation assay
68
450
1.63
3.09
5.8
3.0
s
30.7
29.9
0.44
63
438
(3003396) Base excess in Arterial blood by calculation
49
297
1.75
3.08
13.0
8.1
mmol/l
1.1
1.2
0.06
39
239
(3027801) Oxygen [Partial pressure] in Arterial blood
49
297
1.75
3.08
13.0
8.0
kpa
11.5
11.8
0.17
44
286
(3035350) Ketones [Presence] in Urine by Test strip
172
1393
1.46
3.05
6.0
3.9
estimate
0.0
0.0
0.00
39
289
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
81
2.42
3.04
1.3
1.5
ug/g
222.8
263.1
—
10
47
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
12
5.93
3.03
2.3
1.8
ug/l
38.8
61.9
—
7
12
(3021601) Nitrite [Presence] in Urine by Test strip
172
1402
1.44
2.90
8.3
5.2
estimate
0.0
0.0
0.00
40
288
(3009261) Glucose [Presence] in Urine by Test strip
173
1420
1.43
2.77
6.1
4.0
estimate
0.0
0.0
0.50
40
282
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.43
2.75
1.4
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
55
357
1.64
2.70
3.3
2.2
ug/g
161.9
136.9
0.19
42
273
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
24
3.82
2.69
3.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
19
86
2.28
2.69
1.5
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
87
629
1.51
2.69
8.5
4.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
90
658
1.49
2.63
1.7
1.6
nmol/l
19.9
21.0
0.24
74
552
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
69
2.38
2.52
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
103
2.10
2.47
2.2
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
22
110
2.07
2.46
1.3
1.9
u/l
39.9
38.8
0.09
16
97
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
35
2.91
2.32
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
35
2.91
2.32
1.1
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
59
2.43
2.32
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
447
1.53
2.31
2.3
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
143
1.88
2.26
5.8
3.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
40
609
0.61
2.25
4.5
4.6
%
23.1
20.8
0.29
17
302
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
653
1.44
2.20
5.0
3.8
—
—
—
0
0
(4146454)
8
24
3.39
2.19
3.3
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
24
3.39
2.19
1.5
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
30
3.05
2.16
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
14
4.34
2.16
2.2
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
103
2.00
2.10
4.7
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
103
2.00
2.10
4.7
2.3
g/l
4.5
3.7
0.51
15
79
(3036071) Salmonella sp Ab [Titer] in Serum
5
10
5.05
2.07
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
10
5.05
2.07
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
1085
1.36
2.05
5.1
3.9
ng/l
31.7
41.9
0.90
105
771
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
15
4.05
2.04
1.5
1.1
u/l
99.8
99.8
—
6
10
(3017704) Immunofixation for Urine
6
15
4.05
2.04
2.0
1.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
6
15
4.05
2.04
1.5
1.1
u/l
24.5
38.8
—
6
10
(40768795) Lymph node Pathology biopsy report
8
26
3.12
2.02
1.9
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
195
1.70
2.01
3.4
2.6
ml/min/173m2
38.5
61.7
3.41
21
78
(40761536) Microorganisms panel - Urine sediment
40
261
1.60
1.95
9.3
3.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
11
4.59
1.94
1.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
11
4.59
1.94
1.8
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
27
3.01
1.94
2.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
27
3.01
1.94
9.0
2.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
33
2.77
1.94
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
92
2.01
1.93
1.4
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
39
2.61
1.93
3.8
3.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
79
2.07
1.88
1.8
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
537
1.43
1.88
4.5
3.8
ng/l
133.5
283.8
0.72
65
420
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
17
3.57
1.84
1.3
2.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
17
3.57
1.84
1.3
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
17
3.57
1.84
1.3
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
12
4.21
1.83
1.8
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
23
3.08
1.81
2.4
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
41
2.48
1.77
1.1
1.1
—
—
—
0
0
(44790047)
9
36
2.54
1.75
2.1
1.8
—
—
—
0
0
(44790048)
9
36
2.54
1.75
2.1
1.8
—
—
—
0
0
(44790049)
9
36
2.54
1.75
2.1
1.8
—
—
—
0
0
(44806118)
9
36
2.54
1.75
2.1
1.8
—
—
—
0
0
(3019225) pH of Specimen
38
252
1.57
1.74
9.3
4.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
30
2.70
1.73
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
13
3.88
1.72
1.0
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
42
2.42
1.69
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
42
2.42
1.69
2.5
2.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
107
867
1.34
1.68
3.7
2.1
u/l
106.4
309.9
1.88
101
813
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
62
2.14
1.67
1.8
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
16
83
1.97
1.67
1.4
1.3
—
2.5
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
25
2.84
1.66
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
14
3.61
1.62
1.0
1.0
—
—
—
0
0
(4198724)
5
14
3.61
1.62
1.0
2.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
14
3.61
1.62
4.2
1.6
u/ml
1321.8
905.8
—
5
14
(3035285) Chloride [Moles/volume] in Venous blood
10
43
2.36
1.61
2.5
2.7
mmol/l
104.7
106.0
—
10
43
(3041354) Potassium [Moles/volume] in Venous blood
10
43
2.36
1.61
2.5
2.7
mmol/l
4.1
4.0
—
10
43
(40768804) Tissue Pathology biopsy report
129
1082
1.30
1.57
2.5
2.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
64
2.07
1.56
1.2
1.2
—
42.3
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
8
33
2.46
1.54
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
33
2.46
1.54
1.3
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
27
170
1.64
1.54
3.3
3.5
pmol/l
4.4
4.6
0.68
22
148
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
15
3.37
1.53
1.2
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.8
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.8
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.8
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.8
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
58
2.11
1.51
2.7
2.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
200
1782
1.28
1.51
4.6
3.1
u/l
72.4
47.2
1.19
183
1675
(3035637) Corticotropin [Mass/volume] in Plasma
9
38
2.40
1.46
3.3
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
28
2.53
1.46
1.7
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
16
3.15
1.44
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
200
1790
1.27
1.42
4.1
3.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
29
2.44
1.40
1.3
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
17
2.97
1.36
3.0
1.5
u/l
13.4
13.5
—
5
17
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
99
1.75
1.29
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
100
1.74
1.26
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
15
85
1.80
1.25
9.2
4.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
25
2.42
1.25
1.8
3.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
164
1.56
1.24
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
33
231
1.47
1.23
2.0
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
101
1.72
1.22
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
67
531
1.32
1.22
3.7
2.9
mmol/l
2.4
2.5
0.13
53
466
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
1.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
47
354
1.38
1.18
1.5
1.3
titre
337.8
529.4
—
9
81
(3008295) Osmolality of Serum or Plasma
0
33
0.00
1.16
0.0
1.5
—
275.0
—
0
23
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
95
1.72
1.15
5.1
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
20
2.52
1.15
1.8
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
270
2535
1.27
1.14
32.3
13.6
ml/min/173m2
74.3
81.5
3.97
228
2059
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
292
2769
1.31
1.14
43.4
14.7
mg/l
31.0
23.1
3.17
268
2193
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
339
1.38
1.14
4.2
4.5
%
31.4
31.8
0.07
30
223
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
30
2.36
1.13
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
26
177
1.51
1.11
3.9
4.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
264
2476
1.26
1.10
38.0
15.7
%
37.3
39.4
2.86
175
1774
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
21
2.40
1.09
2.0
3.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
137
1.57
1.08
24.6
10.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
196
1.47
1.06
2.5
3.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
22
2.29
1.03
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
1.6
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
34
2.08
1.03
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
444
0.72
1.03
3.2
3.0
ug/l
1.6
0.7
0.36
22
301
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
99
1.65
1.01
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
35
2.02
1.00
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
49
1.86
0.99
1.7
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
49
1.86
0.99
3.2
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
23
2.19
0.98
1.6
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
29
0.00
0.98
0.0
3.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
36
1.96
0.97
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
2616
0.82
0.97
5.0
4.5
mmol/l
6.0
5.9
0.50
213
2368
(21494755) Public health laboratory ask at order entry panel
13
209
0.61
0.97
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
28
2.16
0.92
1.8
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
39
299
1.34
0.91
3.4
3.8
ug/l
68.6
42.8
0.15
33
251
(3041096) Erythrocytes [Presence] in Urine by Automated
93
798
1.22
0.90
6.5
3.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.7
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.7
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.7
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
45
1.80
0.85
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
180
1.42
0.84
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
82
699
1.23
0.84
1.2
1.3
u/ml
0.5
1.5
1.99
15
193
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
163
1.44
0.84
4.6
3.1
e6/l
0.0
0.1
1.27
23
158
(3002256) Pathology report gross observation
44
350
1.29
0.81
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
94
816
1.21
0.81
4.7
3.2
mmol/l
6.3
7.5
1.49
70
689
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
33
1.83
0.79
1.8
1.3
—
—
—
0
0
(4268621)
6
33
1.83
0.79
3.0
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
90
780
1.21
0.79
5.7
4.0
mg/mmol
20.3
9.3
1.03
54
501
(3023410) Appearance of Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
75
1.62
0.76
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
24
2.10
0.75
1.8
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
55
1.65
0.74
1.3
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
447
1.25
0.73
1.4
1.3
iu/ml
27.1
32.8
0.25
24
147
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
25
2.01
0.73
3.0
1.2
u/l
194.4
309.5
—
5
25
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
42
1.68
0.68
2.0
1.5
—
—
—
0
0
(4281824)
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
176
1889
0.86
0.68
5.1
3.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
43
1.64
0.67
2.0
7.6
mmol/l
5.5
6.3
—
7
36
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
70
1.59
0.66
1.4
2.0
mg/l
9.4
11.4
0.46
11
65
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
69
597
1.19
0.62
1.7
1.7
pmol/l
529.1
13481348.7
0.50
54
497
(3010813) Leukocytes [#/volume] in Blood
299
3074
0.82
0.62
51.4
21.3
e9/l
7.4
6.7
2.63
292
2968
(3026361) Erythrocytes [#/volume] in Blood
299
3073
0.83
0.60
51.3
21.3
e12/l
4.3
4.5
9.42
292
2969
(3035941) MCH [Entitic mass]
299
3073
0.83
0.60
51.1
21.2
pg
30.0
30.2
1.20
293
3017
(3000034) Microalbumin [Mass/volume] in Urine
0
21
0.00
0.60
0.0
3.9
—
21.2
—
0
16
(3024731) MCV [Entitic volume]
299
3072
0.83
0.59
51.2
21.3
fl
91.2
90.9
0.53
293
3017
(3007461) Platelets [#/volume] in Blood
299
3071
0.83
0.58
51.3
21.3
e9/l
262.1
251.0
1.61
292
2978
(3037121) Protein [Mass/volume] in Urine
15
107
1.42
0.56
5.9
4.0
g/l
0.7
0.2
—
10
51
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
65
1.55
0.56
1.4
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
37
1.63
0.56
1.2
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
37
1.63
0.56
1.3
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
204
0.72
0.54
1.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
84
749
1.16
0.54
4.5
3.3
mg/l
111.6
302.7
0.70
54
489
(3003338) MCHC [Mass/volume]
219
2294
0.88
0.53
42.6
19.0
g/l
329.1
332.0
3.94
213
2276
(3050129) First trimester maternal screen panel - Serum or Plasma
6
97
0.61
0.53
2.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
316
1.23
0.52
1.3
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
6
40
1.51
0.52
1.2
1.3
—
75.1
—
0
5
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
63
716
0.85
0.51
1.8
1.6
mmol/l
1.4
1.3
0.16
50
601
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
67
1.51
0.50
1.4
1.3
—
1.0
—
0
6
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
128
1.34
0.48
1.1
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
47
1.50
0.48
2.1
1.9
u/ml
4.1
96.9
—
7
41
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
119
1097
1.13
0.47
6.9
4.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
142
0.70
0.47
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
81
897
0.87
0.47
3.3
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
257
2654
0.88
0.44
5.0
4.9
mmol/l
2.6
2.7
0.39
225
2422
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
31
1.62
0.43
1.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
542
1.15
0.42
1.7
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
105
1.35
0.41
4.1
2.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
9.1
—
0.6
—
0
16
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.7
—
26.8
—
0
5
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
11
80
1.39
0.39
5.5
2.1
ug/min
129.3
63.5
—
6
42
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
80
1.39
0.39
1.3
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
36
1.39
0.38
1.6
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
69
758
0.89
0.36
4.3
5.2
ug/l
5.2
2.7
0.28
57
669
(3001019) Free T4 and TSH panel - Serum or Plasma
9
122
0.73
0.36
2.1
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
251
2582
0.90
0.35
4.7
4.4
mmol/l
1.4
1.5
1.02
220
2362
(3002385) Erythrocyte distribution width [Ratio]
226
2331
0.92
0.31
45.3
18.0
%
14.2
13.7
5.23
220
2286
(3003694) ABO and Rh group [Type] in Blood
84
778
1.10
0.31
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
441
1.13
0.30
1.4
1.3
u/ml
4.2
9.8
0.84
17
181
(3029937) Albumin [Presence] in Urine by Test strip
85
790
1.10
0.29
7.4
4.3
estimate
0.0
0.0
0.00
38
280
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
167
1.21
0.29
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
27
233
1.17
0.28
3.3
3.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
288
2824
1.11
0.28
42.6
16.7
mmol/l
139.1
139.6
2.61
282
2735
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
63
1.28
0.28
1.5
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
254
2599
0.92
0.27
4.6
4.4
mmol/l
4.6
4.6
0.17
221
2390
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
149
0.80
0.26
1.9
1.5
—
—
—
0
0
(4010399)
24
207
1.17
0.26
1.5
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
81
0.74
0.24
2.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
81
0.74
0.24
2.2
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
81
0.74
0.24
2.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
81
0.74
0.24
2.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
143
1.20
0.23
2.5
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
93
0.75
0.22
2.0
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
93
0.75
0.22
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
107
1.22
0.22
1.3
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
107
1.22
0.22
1.3
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
59
634
0.92
0.21
5.7
4.3
kg/l
1.0
1.0
—
8
85
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4211845)
0
13
0.00
0.21
0.0
4.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
108
1.21
0.20
1.3
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
281
0.88
0.20
2.0
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
287
2827
1.08
0.20
43.7
16.8
mmol/l
4.0
4.0
3.09
281
2736
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
328
1.11
0.19
13.9
7.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
28
252
1.12
0.18
1.9
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
70
1.15
0.16
1.5
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
130
1.16
0.16
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
102
1.18
0.15
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
285
2884
0.94
0.15
33.4
13.6
—
—
—
0
0
(4034850)
7
87
0.80
0.14
19.9
11.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
245
2486
0.95
0.13
4.4
3.9
mmol/l
1.4
1.2
1.85
213
2263
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
197
0.91
0.10
1.4
1.3
iu/ml
18.0
140.1
—
6
73
(3027944) Amphetamines [Presence] in Urine
12
106
1.14
0.10
1.1
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
87
1.15
0.09
1.3
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
57
1.05
0.08
1.2
3.0
u/ml
22.3
29.3
—
6
57
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
45
432
1.05
0.07
1.7
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
85
1.06
0.07
2.0
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
295
0.94
0.06
1.8
1.7
—
—
—
0
0
(1002224) Polysomnography panel
9
104
0.86
0.06
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
12
109
1.10
0.06
2.3
1.6
iu/l
14.4
23.6
—
7
93
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
160
1.07
0.04
1.5
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
24
251
0.95
0.04
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
101
1.09
0.04
1.3
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
210
0.95
0.03
1.6
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
35
356
0.98
0.00
2.3
2.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
152
0.99
0.00
1.9
3.1
u/ml
106.9
39.1
0.76
15
147
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
246
2458
1.00
0.00
7.5
5.8
mmol/mol
41.9
39.8
1.71
222
2267
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
214
2136
1.00
0.00
4.2
4.0
pmol/l
14.5
14.9
1.07
188
1914
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
32
325
0.98
0.00
2.1
2.0
—
—
—
0
0
(3020891) Body temperature
11
106
1.04
0.00
5.5
4.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
290
2904
0.99
0.00
20.3
10.4
u/l
24.9
24.8
0.03
279
2786
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
256
2555
1.01
0.00
5.2
4.8
mu/l
1.8
1.9
0.76
226
2311
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
32.2
—
0
6
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
18.3
—
0
6
(4094501)
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
23.3
—
0
6
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
3.4
—
0
6
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
48.8
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
6.9
—
0
6
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
66
0.91
0.00
1.3
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
80
1.00
0.00
1.4
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_BACT_INOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_BACT_INOTHER | 2.026 [1.66, 2.48] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.22 |
During the follow-up period (1.1.1998 — 31.12.2019), 562 out of 1325 females with AB1_OTHER_BACT_INOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_OTHER_BACT_INOTHER | 2.755 [2.11, 3.59] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 352 out of 852 males with AB1_OTHER_BACT_INOTHER died.
Mortality risk
Mortality risk for people of age
years, who have AB1_OTHER_BACT_INOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.208% | 0.509% |
| 5 | 1.246% | 2.961% |
| 10 | 3.141% | 7.155% |
| 15 | 5.804% | 13.554% |
| 20 | 10.293% | 21.955% |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_BACT_INOTHER – Other bacterial agents as the cause of diseases classified to other chapters
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data